Thu, Apr 17, 2014, 6:56 AM EDT - U.S. Markets open in 2 hrs 34 mins

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • billrichardson081 billrichardson081 Sep 21, 2013 10:23 AM Flag

    Interview091913 - Daniel O'Connor Talks Cancer Immunotherapy

    At NYSE Floor. http://www.nasdaq.com/video/interview091913-daniel-oconnor-talks-cancer-immunotherapy-company-advaxis-517941464

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • means nothing. Talk is cheap and the big pharmas will never allow cancer cures because of all the billions they would lose in revenue. Plus all the job loses in health care industry. No way will they ever allow cures, and in fact they will create new cancers.

      • 1 Reply to fallenangelsthree
      • an_unknown_poster_of_means an_unknown_poster_of_means Sep 22, 2013 12:45 AM Flag

        "the big pharmas will never allow cancer cures "
        -------------------------------------------------------------------

        "A new study shows that children with the most common type of childhood cancer, acute lymphoblastic leukemia (ALL) have a survival rate of more than 90%. ALL accounts for about 3 out of 4 cases of childhood leukemia.

        The research included more than 21,000 children with ALL, more than half the patients in the United States. They took part in the Children’s Oncology Group clinical trials from 1990 to 2005.

        Researchers from the University of Colorado Cancer Center found that the 5-year survival rate for children and adolescents with ALL improved from 83.7% for those diagnosed between 1990 and 1994, to 90.4% for those diagnosed between 2000 and 2005. In the 1960s, the 5-year survival rate was less than 10%. The survival rates increased for girls and boys of all racial and ethnic groups and for all age groups except infants under 1 year old. Improvements in survival for African-American patients with ALL were so significant, they narrowed the racial survival gap.

        Researchers attribute the improved survival rates to clinical trials that helped doctors learn the best drugs and dosages to treat children with ALL."

 
PFE
30.09+0.20(+0.67%)Apr 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Schlumberger Limited
NYSEWed, Apr 16, 2014 4:00 PM EDT
Google Inc.
NasdaqGSWed, Apr 16, 2014 4:00 PM EDT